Literature DB >> 21377471

Enhanced immune defences in Pacific white shrimp (Litopenaeus vannamei) post-exposure to a vibrio vaccine.

Adam Powell1, Edward C Pope, Fiona E Eddy, Emily C Roberts, Robin J Shields, Michael J Francis, Patrick Smith, Sylvie Topps, Jim Reid, Andrew F Rowley.   

Abstract

This study was conducted to determine if exposure of shrimp, Litopenaeus vannamei, to a commercial anti-vibrio vaccine caused changes in antibacterial and cellular (phagocytosis) defences. Shrimp post-larvae were administered either Vibromax™ vaccine or a blank preparation. Whole body homogenates were prepared before (day 0), during (day 10) and after (day 20) vaccination and incubated with a selection of pathogenic vibrios. Homogenate from day 0 animals showed natural antibacterial activity towards Vibrioanguillarum which was significantly enhanced for bacteria-exposed shrimp at 10 days post-challenge. This effect of the vaccine was short-term in its duration. No antibacterial activity was observed in day 0 shrimp homogenate against Vibrio alginolyticus but it was significantly enhanced for both vaccinated and blank-vaccinated shrimp by day 10. No natural or inducible antibacterial activity was observed against Vibrio harveyi at 0, 10 or 20 days post-challenge. To determine if prior exposure of shrimp to inactivated vibrios results in elevated hemocyte phagocytic activity, juveniles were injected with either a mixture of formalin-inactivated vibrios or saline. Hemocyte monolayers made from these shrimp were overlaid with a 1:1 mix of Bacillus subtilis and these vibrios. Hemocytes from vibrio-exposed animals showed elevated levels of internalised vibrios compared with those from the saline injected group. These studies show selectively enhanced cellular defences of shrimp following 'vaccination'.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377471     DOI: 10.1016/j.jip.2011.02.006

Source DB:  PubMed          Journal:  J Invertebr Pathol        ISSN: 0022-2011            Impact factor:   2.841


  7 in total

1.  Immunogenic characterization and protective efficacy of recombinant CsgA, major subunit of curli fibers, against Vibrio parahaemolyticus.

Authors:  Sweta Karan; Devapriya Choudhury; Aparna Dixit
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-06       Impact factor: 4.813

Review 2.  Probiotics in fish and shellfish culture: immunomodulatory and ecophysiological responses.

Authors:  Bidhan C De; D K Meena; B K Behera; Pronob Das; P K Das Mohapatra; A P Sharma
Journal:  Fish Physiol Biochem       Date:  2014-01-14       Impact factor: 2.794

3.  Use of Bacteriophages to Control Vibrio Contamination of Microalgae Used as a Food Source for Oyster Larvae During Hatchery Culture.

Authors:  Tuan Son Le; Paul C Southgate; Wayne O'Connor; Tomer Abramov; Daniel Shelley; Sang V Vu; D İpek Kurtböke
Journal:  Curr Microbiol       Date:  2020-04-24       Impact factor: 2.188

4.  Identification of antigenic domains and peptides from VP15 of white spot syndrome virus and their antiviral effects in Marsupenaeus japonicus.

Authors:  Jirayu Boonyakida; Jian Xu; Jun Satoh; Takafumi Nakanishi; Tohru Mekata; Tatsuya Kato; Enoch Y Park
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

5.  Enhanced cellular immunity in shrimp (Litopenaeus vannamei) after 'vaccination'.

Authors:  Edward C Pope; Adam Powell; Emily C Roberts; Robin J Shields; Robin Wardle; Andrew F Rowley
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

6.  Vaccination enhances early immune responses in white shrimp Litopenaeus vannamei after secondary exposure to Vibrio alginolyticus.

Authors:  Yong-Chin Lin; Jiann-Chu Chen; Wan Zabidii W Morni; Dedi Fazriansyah Putra; Chien-Lun Huang; Chang-Che Li; Jen-Fang Hsieh
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

7.  Next-generation sequencing-based transcriptome analysis of Helicoverpa armigera Larvae immune-primed with Photorhabdus luminescens TT01.

Authors:  Zengyang Zhao; Gongqing Wu; Jia Wang; Chunlin Liu; Lihong Qiu
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.